FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of
custom and performance chemicals and biofuels, today announced
financial results for the second quarter ended June 30,
2024.
Second quarter
2024 Financial Highlights (all
comparisons are with the second quarter of 2023)
- Revenues were $72.4 million,
a decrease of 15% or $12.9 million compared
to $85.3 million.
- Net income was $9.6 million,
or $0.22 per diluted share, up from a net loss
of $9.9 million, or $0.23 per diluted share.
- Adjusted EBITDA(1) was
$6.9 million, up from ($7.3) million.
Six
months 2024 Financial
Highlights (all comparisons are with the first six
months of 2023)
- Revenues were $130.7 million,
a decrease of 18% or $28.8 million compared
to $159.5 million.
- Net income
was $13.9 million, or $0.32 per diluted share,
up from $11.2 million, or $0.26 per
diluted share.
- Adjusted EBITDA(1) was $14.0
million, up from $8.6 million.
(1) A non-GAAP financial measure. See “Non-GAAP
Financial Measures” for a description of the measure and a
reconciliation to the applicable GAAP measure.
“Our net income of $9.6 million for the quarter reflects a solid
performance when set against a backdrop of a recovering chemical
industry from the 2023 downturn and a very competitive Biofuels
market. We sold the majority of the separated RINs that we
generated during the quarter to close with a significantly reduced
RIN inventory fair market value position of $1.1 million compared
to $19.5 million at June 30, 2023. As we hold these inventories at
zero cost, this is the most significant contributor to the
improvement in our earnings quarter on quarter.
“Biodiesel and RIN prices this year remained low compared to
2023 resulting in reduced revenues and compressed margins. Sales
volumes were also a little lower in the second quarter as
production issues primarily stemming from extreme winter weather
experienced during the three-month period ended March 31, 2024,
precluded us from building the biodiesel inventories we would
typically sell in the three months ended June 30, 2024.
“In our Chemicals segment, glycerin prices were also
significantly lower than the same period last year and sales
volumes were reduced by the production disruption in the first
quarter of this year. We also experienced reduced sales
volumes of chemicals sold into the agricultural and energy markets,
but these were partially offset by increased volumes of chemicals
sold into the automotive coatings market as well as sales of one
new product into the coatings market,” said Tom McKinlay, Chief
Executive Officer for FutureFuel Corp.
2024 Cash Dividends
FutureFuel paid a special cash dividend of $2.50 per share
on common stock on April 9, 2024. FutureFuel also
paid a regular quarterly cash dividend in the second quarter
in the amount of $0.06 per share on our common stock. The
remaining 2024 quarterly dividends of $0.06 per share will be paid
in September and December.
Financial Overview and Key Operating
Metrics
Financial and operating metrics, which include
non-GAAP financial measures (see “Non-GAAP Financial Measures” for
additional information), include all dollar amounts in
thousands, except per share amounts:
|
FutureFuel Corp.Certain Financial and Operating
Metrics(Unaudited) |
|
|
Three Months Ended June 30, |
|
|
|
|
|
|
|
|
Dollar |
|
% |
|
|
2024 |
|
2023 |
|
Change |
|
Change |
|
Revenue |
$ |
72,409 |
|
$ |
85,308 |
|
$ |
(12,899 |
) |
|
(15 |
)% |
Income (loss) from
operations |
$ |
5,451 |
|
$ |
(11,583 |
) |
$ |
17,034 |
|
|
na |
|
Net income (loss) |
$ |
9,571 |
|
$ |
(9,859 |
) |
$ |
19,430 |
|
|
na |
|
Earnings (loss) per common
share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
0.22 |
|
$ |
(0.23 |
) |
$ |
0.45 |
|
|
na |
|
Diluted |
$ |
0.22 |
|
$ |
(0.23 |
) |
$ |
0.45 |
|
|
na |
|
Adjusted EBITDA |
$ |
6,907 |
|
$ |
(7,329 |
) |
$ |
14,236 |
|
|
na |
|
|
Six Months Ended June 30, |
|
|
|
|
|
|
|
|
Dollar |
|
% |
|
|
2024 |
|
2023 |
|
Change |
|
Change |
|
Revenue |
$ |
130,690 |
|
$ |
159,489 |
|
$ |
(28,799 |
) |
|
(18 |
)% |
Income from operations |
$ |
7,649 |
|
$ |
6,668 |
|
$ |
981 |
|
|
15 |
% |
Net income |
$ |
13,901 |
|
$ |
11,222 |
|
$ |
2,679 |
|
|
24 |
% |
Earnings per common
share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
0.32 |
|
$ |
0.26 |
|
$ |
0.06 |
|
|
23 |
% |
Diluted |
$ |
0.32 |
|
$ |
0.26 |
|
$ |
0.06 |
|
|
23 |
% |
Adjusted EBITDA |
$ |
14,015 |
|
$ |
8,572 |
|
$ |
5,443 |
|
|
63 |
% |
Financial and Business Summary
Consolidated sales revenue in the three months
ended June 30, 2024 decreased $12,899 compared to the three months
ended June 30, 2023. This decline was driven mostly by
lower sales volumes in the biofuel segment of $7,439. Production
issues, primarily stemming from extreme winter weather
experienced during the three-month period ended March 31, 2024,
prevented us from building the biodiesel inventories we would
typically have available to sell in the three months ended June 30,
2024. Also reducing sales revenue in the three-month period, was
lower prices in the biofuel segment of $5,940 due to a decline in
RIN prices with market supply in excess of the EPA RIN mandate. In
our chemical segment, sales revenue increased $1,980 for the three
months ended June 30, 2024, compared to the prior-year period, due
primarily to stronger sales volumes in the
agricultural market, but was mostly offset by reduced sales
prices in chemicals sold into the agricultural and
energy markets and from product mix ($1,500).
Consolidated sales revenue in the six months ended
June 30, 2024 decreased $28,799 compared to the six months
ended June 30, 2023. This decline was driven mostly by
lower prices in the biofuel segment of $17,882 due to a decline in
RIN prices with market supply in excess of the EPA RIN mandate. As
noted above, production issues in the first three months of 2024,
prevented us from building the biodiesel inventories we would
typically have available to sell in the six months ended June 30,
2024. In our chemical segment, sales revenue declined a
net $3,342 ($4,006 on reduced prices on chemicals sold into
the agricultural and energy markets partially offset by
increased volume, $664), compared to the prior-year period.
Income from operations in the three months ended June 30, 2024
increased $17,034 as compared to the same period of 2023,
due primarily to: (i) the benefit of not holding
significant inventory of RINs at the end of the current
three-month period ($1,055 as compared to $19,461 at June 30,
2023); separated RINs are recognized when transferred; (ii)
the change in the mark-to-market derivative position which was an
unrealized gain of $578 as compared to an unrealized loss of
$1,643 in the three months ended June 30, 2024 and 2023,
respectively; and (iii) the change in the adjustment in the
carrying value of our inventory as determined utilizing the LIFO
method of inventory accounting. This adjustment increased gross
profit $1,313 in the three months ended June 30, 2024 and decreased
gross profit $288 in the same period of the prior year.
Partially offsetting these benefits were: (i) the narrowing of the
spread in biofuel price and feedstock price (inclusive of the
effect of the RIN price decline); and (ii) the change in the
activity in derivative instruments with a realized gain of
$835 in the current three-month period as compared to a
realized gain of $6,032 in the prior year period.
The contrasting results in the offsetting items (i) and (ii)
reflect the impact of price movements in the biodiesel market
during the course of each year compared to when we committed to our
feedstock acquisition.
Income from operations in the six months ended June 30, 2024
increased $981 as compared to the same period of 2023, primarily
due to: (i) the benefit of not holding significant inventory
of RINs at the end of the current six-month period as noted
above and (ii) the change in the adjustment in the carrying value
of our inventory as determined utilizing the LIFO method of
inventory accounting. This adjustment increased gross profit
$4,341 in the six months ended June 30, 2024 as compared to an
increase of $3,495 in the same period of 2023. These
improvements were mostly offset by the change in the activity of
derivative instruments with a realized loss of $354 and unrealized
loss of $1,696 in the six months ended June 30, 2024 as compared to
a realized gain of $9,437 and unrealized gain of $3,259 in the same
period of 2023. Income from operations was also
negatively impacted in the six-month period ended June 30, 2024 by
higher costs resulting from the impact of extreme winter
weather.
Capital Expenditures
Capital expenditures were $5,270 in
the first six months of 2024, compared with $3,875 in the
same period in 2023.
Cash and Cash Equivalents
Cash and cash
equivalents totaled $115,060 as of June 30, 2024,
compared with $219,444 as of December 31, 2023. A special
cash dividend of $2.50 per common share was paid April 9,
2024 which totaled $109,408.
About FutureFuel
FutureFuel is a leading manufacturer of
diversified chemical products and biofuels. FutureFuel’s chemicals
segment manufactures specialty chemicals for specific customers
(“custom chemicals”) as well as multi-customer specialty chemicals
(“performance chemicals”). FutureFuel’s custom manufacturing
product portfolio includes proprietary agrochemicals, adhesion
promoters, a biocide intermediate, and an antioxidant precursor.
FutureFuel’s performance chemicals products include a portfolio of
proprietary nylon and polyester polymer modifiers and several
small-volume specialty chemicals and solvents for diverse
applications. FutureFuel’s biofuels segment primarily produces and
sells biodiesel to its customers. Please visit
www.futurefuelcorporation.com for more information.
Forward-Looking Statements
This document contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements deal with
FutureFuel’s current plans, intentions, beliefs, and expectations,
and statements of future economic performance. Statements
containing such terms as “believe,” “do not believe,” “plan,”
“expect,” “intend,” “estimate,” “anticipate,” and other phrases of
similar meaning are considered to contain uncertainty and are
forward-looking statements. In addition, from time-to-time
FutureFuel or its representatives have made or will make
forward-looking statements orally or in writing. Furthermore, such
forward-looking statements may be included in various filings that
the company makes with United States Securities and Exchange
Commission (the “SEC”), in press releases, or in oral statements
made by or with the approval of one of FutureFuel’s authorized
executive officers.
These forward-looking statements are subject to
certain known and unknown risks and uncertainties, as well as
assumptions that could cause actual results to differ materially
from those reflected in these forward-looking statements. Factors
that might cause actual results to differ include, but are not
limited to, those set forth under the headings “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations” in FutureFuel’s Form 10-K Annual Report, as
amended for the year ended December 31, 2023 and in its
future filings made with the SEC. An investor should not place
undue reliance on any forward-looking statements contained in this
document, which reflect FutureFuel management’s opinions only as of
their respective dates. Except as required by law, the company
undertakes no obligation to revise or publicly release the results
of any revisions to forward-looking statements. The risks and
uncertainties described in this document and in current and future
filings with the SEC are not the only ones faced by FutureFuel. New
factors emerge from time to time, and it is not possible for the
company to predict which will arise. There may be additional risks
not presently known to the company or that the company currently
believes are immaterial to its business. In addition, FutureFuel
cannot assess the impact of each factor on its business or the
extent to which any factor, or combination of factors, may cause
actual results to differ materially from those contained in any
forward-looking statements. If any such risks occur, FutureFuel’s
business, operating results, liquidity, and financial condition
could be materially affected in an adverse manner. An investor
should consult any additional disclosures FutureFuel has made or
will make in its reports to the SEC on Forms 10-K, 10-Q, and 8-K,
and any amendments thereto. All subsequent written and oral
forward-looking statements attributable to FutureFuel or persons
acting on its behalf are expressly qualified in their entirety by
the cautionary statements contained in this document.
Non-GAAP Financial Measures
In this press release, FutureFuel used adjusted
EBITDA as a key operating metric to measure both performance and
liquidity. Adjusted EBITDA is a non-GAAP financial measure.
Adjusted EBITDA is not a substitute for operating income, net
income, or cash flow from operating activities (each as determined
in accordance with GAAP), as a measure of performance or liquidity.
Adjusted EBITDA has limitations as an analytical tool, and should
not be considered in isolation or as a substitute for analysis of
results as reported under GAAP. FutureFuel defines adjusted EBITDA
as net income before interest, income taxes, depreciation, and
amortization expenses, excluding, when applicable, non-cash
share-based compensation expense, public offering expenses,
acquisition-related transaction costs, purchase accounting
adjustments, loss on disposal of property and equipment, non-cash
gains or losses on derivative instruments, and other non-operating
income or expense. Information relating to adjusted EBITDA is
provided so that investors have the same data that management
employs in assessing the overall operation and liquidity of
FutureFuel’s business. FutureFuel’s calculation of adjusted EBITDA
may be different from similarly titled measures used by other
companies; therefore, the results of its calculation are not
necessarily comparable to the results of other companies.
Adjusted EBITDA allows FutureFuel’s chief
operating decision makers to assess the performance and liquidity
of FutureFuel’s business on a consolidated basis to assess the
ability of its operating segments to produce operating cash flow to
fund working capital needs, to fund capital expenditures, and to
pay dividends. In particular, FutureFuel management believes that
adjusted EBITDA permits a comparative assessment of FutureFuel’s
operating performance and liquidity, relative to a performance and
liquidity based on GAAP results, while isolating the effects of
depreciation and amortization, which may vary among its operating
segments without any correlation to their underlying operating
performance, and of non-cash stock-based compensation expense,
which is a non-cash expense that varies widely among similar
companies, and non-cash gains and losses on derivative instruments,
whose immediate recognition can cause net income to be volatile
from quarter to quarter due to the timing of the valuation change
in the derivative instruments relative to the sale of biofuel.
A table included in this earnings release
reconciles adjusted EBITDA with net income, the most directly
comparable GAAP performance financial measure, and a table
reconciles adjusted EBITDA with cash flows from operations, the
most directly comparable GAAP liquidity financial measure.
|
|
|
|
|
|
|
FutureFuel Corp.Condensed Consolidated Balance
Sheets(Dollars in
thousands)(Unaudited) |
|
|
|
|
|
|
|
|
June 30, 2024 |
|
December 31, 2023 |
|
Assets |
|
|
|
|
|
|
Cash and cash equivalents |
$ |
115,060 |
|
$ |
219,444 |
|
Accounts receivable, inclusive of the blenders' tax credit of
$14,976 and $11,381, respectively and net of allowances for
expected credit losses of $145 and $55, respectively |
|
33,394 |
|
|
28,407 |
|
Inventory, net |
|
29,516 |
|
|
32,978 |
|
Other current assets |
|
5,671 |
|
|
9,717 |
|
Total current assets |
|
183,641 |
|
|
290,546 |
|
Property, plant and equipment, net |
|
74,070 |
|
|
72,711 |
|
Other assets |
|
3,474 |
|
|
3,824 |
|
Total noncurrent assets |
|
77,544 |
|
|
76,535 |
|
Total
Assets |
$ |
261,185 |
|
$ |
367,081 |
|
Liabilities and
Stockholders’ Equity |
|
|
|
|
|
|
Accounts payable, inclusive of the blenders' tax credit rebates due
customers of $890 and $890 |
$ |
11,420 |
|
$ |
22,220 |
|
Dividends payable |
|
5,251 |
|
|
10,503 |
|
Other current liabilities |
|
16,468 |
|
|
8,621 |
|
Total current liabilities |
|
33,139 |
|
|
41,344 |
|
Deferred revenue – long-term |
|
9,720 |
|
|
12,570 |
|
Other noncurrent liabilities |
|
3,931 |
|
|
3,287 |
|
Total noncurrent liabilities |
|
13,651 |
|
|
15,857 |
|
Total liabilities |
|
46,790 |
|
|
57,201 |
|
Commitments and contingencies |
|
|
|
|
|
|
Preferred stock, $0.0001 par value, 5,000,000 shares authorized,
none issued and outstanding |
|
- |
|
|
- |
|
Common stock, $0.0001 par value, 75,000,000 shares authorized,
43,763,243 shares issued and outstanding as of June 30, 2024 and
December 31, 2023 |
|
4 |
|
|
4 |
|
Additional paid in capital |
|
204,820 |
|
|
282,489 |
|
Retained earnings |
|
9,571 |
|
|
27,387 |
|
Total Stockholders’ Equity |
|
214,395 |
|
|
309,880 |
|
Total Liabilities and
Stockholders’ Equity |
$ |
261,185 |
|
$ |
367,081 |
|
|
FutureFuel Corp.Condensed Consolidated Statements
of Income and Comprehensive Income(Dollars in thousands,
except per share amounts)(Unaudited) |
|
|
Three months ended |
|
Six Months Ended |
|
|
June 30: |
|
June 30: |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
Revenue |
$ |
72,409 |
|
$ |
85,308 |
|
$ |
130,690 |
|
$ |
159,489 |
|
Cost of goods sold and
distribution |
|
63,752 |
|
|
93,900 |
|
|
117,026 |
|
|
146,458 |
|
Gross profit (loss) |
|
8,657 |
|
|
(8,592 |
) |
|
13,664 |
|
|
13,031 |
|
Selling, general, and
administrative expenses |
|
2,290 |
|
|
1,984 |
|
|
4,193 |
|
|
4,284 |
|
Research and development
expenses |
|
916 |
|
|
1,007 |
|
|
1,822 |
|
|
2,079 |
|
Total operating expenses |
|
3,206 |
|
|
2,991 |
|
|
6,015 |
|
|
6,363 |
|
Income (loss) from operations |
|
5,451 |
|
|
(11,583 |
) |
|
7,649 |
|
|
6,668 |
|
Interest and dividend
income |
|
1,521 |
|
|
1,732 |
|
|
4,321 |
|
|
4,068 |
|
Gain on marketable
securities |
|
- |
|
|
42 |
|
|
- |
|
|
575 |
|
Other income (expense)
net |
|
2,605 |
|
|
(35 |
) |
|
2,569 |
|
|
(67 |
) |
Other income (expense) net |
|
4,126 |
|
|
1,739 |
|
|
6,890 |
|
|
4,576 |
|
Income (loss) before income
taxes |
|
9,577 |
|
|
(9,844 |
) |
|
14,539 |
|
|
11,244 |
|
Income tax provision |
|
6 |
|
|
15 |
|
|
638 |
|
|
22 |
|
Net income (loss) |
$ |
9,571 |
|
$ |
(9,859 |
) |
$ |
13,901 |
|
$ |
11,222 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per common
share |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
0.22 |
|
$ |
(0.23 |
) |
$ |
0.32 |
|
$ |
0.26 |
|
Diluted |
$ |
0.22 |
|
$ |
(0.23 |
) |
$ |
0.32 |
|
$ |
0.26 |
|
Weighted average shares
outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
43,763,243 |
|
|
43,763,243 |
|
|
43,763,243 |
|
|
43,763,243 |
|
Diluted |
|
43,763,243 |
|
|
43,763,243 |
|
|
43,763,243 |
|
|
43,764,890 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income
(loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
$ |
9,571 |
|
$ |
(9,859 |
) |
$ |
13,901 |
|
$ |
11,222 |
|
Other comprehensive (loss) income from unrealized net (losses)
gains on available-for-sale securities |
|
- |
|
|
(20 |
) |
|
- |
|
|
2 |
|
Income tax effect |
|
- |
|
|
4 |
|
|
- |
|
|
(1 |
) |
Total other comprehensive (loss) income, net of tax |
|
- |
|
|
(16 |
) |
|
- |
|
|
1 |
|
Comprehensive income
(loss) |
$ |
9,571 |
|
$ |
(9,875 |
) |
$ |
13,901 |
|
$ |
11,223 |
|
|
FutureFuel Corp.Consolidated Statements of Cash
Flows(Dollars in
thousands)(Unaudited) |
|
|
Six Months Ended June 30, |
|
|
2024 |
|
2023 |
|
Cash flows from operating activities |
|
|
|
|
|
|
Net income |
$ |
13,901 |
|
$ |
11,222 |
|
Adjustments to reconcile net income to net cash provided by (used
in) operating activities: |
|
|
|
|
|
|
Depreciation |
|
4,760 |
|
|
5,155 |
|
Amortization of deferred financing costs |
|
51 |
|
|
49 |
|
Provision for deferred income taxes |
|
626 |
|
|
- |
|
Change in fair value of equity securities |
|
- |
|
|
(3,117 |
) |
Change in fair value of derivative instruments |
|
1,696 |
|
|
(3,259 |
) |
Loss on the sale of investments |
|
- |
|
|
2,543 |
|
Stock based compensation |
|
22 |
|
|
- |
|
Loss on disposal of property, plant, and equipment |
|
- |
|
|
8 |
|
Noncash interest expense |
|
18 |
|
|
17 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
Accounts receivable |
|
(4,980 |
) |
|
(2,369 |
) |
Accounts receivable – related parties |
|
(7 |
) |
|
(1 |
) |
Inventory |
|
3,462 |
|
|
(40,601 |
) |
Income tax receivable |
|
(20 |
) |
|
19 |
|
Prepaid expenses |
|
2,156 |
|
|
1,706 |
|
Other assets |
|
555 |
|
|
(4,502 |
) |
Accounts payable |
|
(11,649 |
) |
|
(6,269 |
) |
Accounts payable – related parties |
|
- |
|
|
24 |
|
Accrued expenses and other current liabilities |
|
6,710 |
|
|
321 |
|
Accrued expenses and other current liabilities – related
parties |
|
- |
|
|
(1 |
) |
Deferred revenue |
|
(1,713 |
) |
|
(2,037 |
) |
Other noncurrent liabilities |
|
- |
|
|
427 |
|
Net cash provided by (used in) operating
activities |
|
15,588 |
|
|
(40,665 |
) |
Cash flows from
investing activities |
|
|
|
|
|
|
Collateralization of derivative instruments |
|
(42 |
) |
|
3,154 |
|
Proceeds from the sale of marketable securities |
|
- |
|
|
37,701 |
|
Capital expenditures |
|
(5,270 |
) |
|
(3,875 |
) |
Net cash (used in) provided by investing
activities |
|
(5,312 |
) |
|
36,980 |
|
Cash flows from
financing activities |
|
|
|
|
|
|
Payment of dividends |
|
(114,660 |
) |
|
(5,251 |
) |
Deferred financing costs |
|
- |
|
|
(14 |
) |
Net cash used in financing activities |
|
(114,660 |
) |
|
(5,265 |
) |
Net change in cash and cash
equivalents |
|
(104,384 |
) |
|
(8,950 |
) |
Cash and cash equivalents at
beginning of period |
|
219,444 |
|
|
175,640 |
|
Cash and cash
equivalents at end of period |
$ |
115,060 |
|
$ |
166,690 |
|
|
|
|
|
|
|
|
Cash paid for income
taxes |
$ |
- |
|
$ |
20 |
|
Noncash capital
expenditures |
$ |
1,182 |
|
$ |
244 |
|
|
FutureFuel Corp.Reconciliation of Non-GAAP
Financial Measure to Financial Measure(Dollars in
thousands)(Unaudited) |
|
Reconciliation of Adjusted EBITDA to Net
Income |
|
|
Three months ended |
|
Six Months Ended |
|
|
June 30: |
|
June 30: |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
Net income (loss) |
$ |
9,571 |
|
$ |
(9,859 |
) |
$ |
13,901 |
|
$ |
11,222 |
|
Depreciation |
|
2,145 |
|
|
2,604 |
|
|
4,760 |
|
|
5,155 |
|
Non-cash stock-based
compensation |
|
- |
|
|
- |
|
|
22 |
|
|
- |
|
Interest and dividend
income |
|
(1,521 |
) |
|
(1,732 |
) |
|
(4,321 |
) |
|
(4,068 |
) |
Non-cash interest expense and
amortization of deferred financing costs |
|
34 |
|
|
34 |
|
|
69 |
|
|
67 |
|
Loss on disposal of property
and equipment |
|
- |
|
|
8 |
|
|
- |
|
|
8 |
|
Unrealized (gain) loss on
derivative instruments |
|
(578 |
) |
|
1,643 |
|
|
1,696 |
|
|
(3,259 |
) |
Gain on marketable
securities |
|
- |
|
|
(42 |
) |
|
- |
|
|
(575 |
) |
Other income |
|
(2,750 |
) |
|
- |
|
|
(2,750 |
) |
|
- |
|
Income tax provision |
|
6 |
|
|
15 |
|
|
638 |
|
|
22 |
|
Adjusted EBITDA |
$ |
6,907 |
|
$ |
(7,329 |
) |
$ |
14,015 |
|
$ |
8,572 |
|
|
Reconciliation of Adjusted EBITDA to Net Cash Provided by
Operating Activities |
|
|
Six Months Ended |
|
|
June 30: |
|
|
2024 |
|
2023 |
|
Net cash provided by (used in) operating activities |
$ |
15,588 |
|
$ |
(40,665 |
) |
Deferred income taxes,
net |
|
(626 |
) |
|
- |
|
Interest and dividend
income |
|
(4,321 |
) |
|
(4,068 |
) |
Income tax provision |
|
638 |
|
|
22 |
|
Changes in operating assets
and liabilities, net |
|
5,486 |
|
|
53,283 |
|
Other income |
|
(2,750 |
) |
|
- |
|
Adjusted EBITDA |
$ |
14,015 |
|
$ |
8,572 |
|
|
FutureFuel Corp.Condensed Consolidated Segment
Income(Dollars in
thousands)(Unaudited) |
|
|
Three months ended |
|
Six Months Ended |
|
|
June 30: |
|
June 30: |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
Custom chemicals |
$ |
15,583 |
|
$ |
15,576 |
|
$ |
31,010 |
|
$ |
32,196 |
|
Performance chemicals |
|
3,653 |
|
|
3,180 |
|
|
6,285 |
|
|
8,441 |
|
Chemical revenue |
|
19,236 |
|
|
18,756 |
|
|
37,295 |
|
|
40,637 |
|
Biofuel revenue |
|
53,173 |
|
|
66,552 |
|
|
93,395 |
|
|
118,852 |
|
Total Revenue |
$ |
72,409 |
|
$ |
85,308 |
|
$ |
130,690 |
|
$ |
159,489 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment gross profit
(loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Chemical |
$ |
4,677 |
|
$ |
6,416 |
|
$ |
8,698 |
|
$ |
15,039 |
|
Biofuel |
|
3,980 |
|
|
(15,008 |
) |
|
4,966 |
|
|
(2,008 |
) |
Total gross profit (loss) |
$ |
8,657 |
|
$ |
(8,592 |
) |
$ |
13,664 |
|
$ |
13,031 |
|
As of June 30, 2024, FutureFuel held
2.1 million RINs with a fair market value of
$1,055. Comparatively, at June 30, 2023, FutureFuel
held 11.8 million RINs with a fair market value
of $19,461.
COMPANY CONTACTFutureFuel
Corp.Tom McKinlay(314)
854-8352www.futurefuelcorporation.com
FutureFuel (NYSE:FF)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
FutureFuel (NYSE:FF)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024